Lea T. Drye
Blue Cross Blue Shield Association(US)
Publications by Year
Research Areas
Dementia and Cognitive Impairment Research, Ocular Diseases and Behçet’s Syndrome, Schizophrenia research and treatment, Attention Deficit Hyperactivity Disorder, Alzheimer's disease research and treatments
Most-Cited Works
- → Effect of Citalopram on Agitation in Alzheimer Disease(2014)551 cited
- → Sertraline for the Treatment of Depression in Alzheimer Disease(2010)242 cited
- → Safety and Efficacy of Methylphenidate for Apathy in Alzheimer’s Disease(2013)186 cited
- → Sertraline for the Treatment of Depression in Alzheimer Disease: Week-24 Outcomes(2010)183 cited
- → Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer’s Dementia: Evidence From the CitAD Study(2016)98 cited
- → Celecoxib or Naproxen Treatment Does Not Benefit Depressive Symptoms in Persons Age 70 and Older: Findings From a Randomized Controlled Trial(2011)96 cited
- → Outcome of Treatment of Uveitic Macular Edema(2015)95 cited
- → Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer’s Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial(2016)94 cited
- → Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis(2015)91 cited
- → The Effects of Four Doses of Vitamin D Supplements on Falls in Older Adults(2020)89 cited